Literature DB >> 21429956

Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia, a literature review of evidence.

Genevieve Henry1, Deena Williamson, Rajesh R Tampi.   

Abstract

The objective of this review is to summarize the current data on the use of antidepressants in the treatment of behavioral and psychological symptoms of dementia (BPSD) and to determine whether these medications can be recommended for routine clinical use. A literature search of six major databases (PubMed, Medline, PsychINFO, Scopus, Web of Science and Cochrane collaboration) trials, 8 using a selective serotonin reuptake inhibitor (SSRI) compound and 3 using trazodone showed benefit in the treatment of BPSD. The antidepressant drug was well tolerated in at least 14 of the 19 trials with information about tolerability in one trial not provided in the study (paroxetine or placebo for FTD). This review indicates that antidepressants can be an effective in the treatment of BPSD and are generally well tolerated in elderly demented patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21429956     DOI: 10.1177/1533317511402051

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  19 in total

1.  Behavioral disturbance in dementia.

Authors:  Abhilash K Desai; Lori Schwartz; George T Grossberg
Journal:  Curr Psychiatry Rep       Date:  2012-08       Impact factor: 5.285

2.  Serotonin as a putative scavenger of hypohalous acid in the brain.

Authors:  Mike Kalogiannis; E James Delikatny; Thomas M Jeitner
Journal:  Biochim Biophys Acta       Date:  2015-12-14

Review 3.  The Use of Cannabinoids in Treating Dementia.

Authors:  Megan Weier; Wayne Hall
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

Review 4.  Depression in cognitive impairment.

Authors:  Laurel D Pellegrino; Matthew E Peters; Constantine G Lyketsos; Christopher M Marano
Journal:  Curr Psychiatry Rep       Date:  2013-09       Impact factor: 5.285

5.  Relationships of depressive behavior and sertraline treatment with walking speed and activity in older female nonhuman primates.

Authors:  Jamie N Justice; Marnie G Silverstein-Metzler; Beth Uberseder; Susan E Appt; Thomas B Clarkson; Thomas C Register; Stephen B Kritchevsky; Carol A Shively
Journal:  Geroscience       Date:  2017-10-28       Impact factor: 7.713

6.  Trends, correlates, and disease patterns of antidepressant use among elderly persons in Taiwan.

Authors:  Chia-Lun Kuo; I-Chia Chien; Ching-Heng Lin; Shu-Wen Cheng
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-03-31       Impact factor: 4.328

7.  Effects of long-term sertraline treatment and depression on coronary artery atherosclerosis in premenopausal female primates.

Authors:  Carol A Shively; Thomas C Register; Susan E Appt; Thomas B Clarkson
Journal:  Psychosom Med       Date:  2015-04       Impact factor: 4.312

Review 8.  Management of Behavioral and Psychological Symptoms of Dementia.

Authors:  Eylem Şahin Cankurtaran
Journal:  Noro Psikiyatr Ars       Date:  2014-12-01       Impact factor: 1.339

Review 9.  The impact of treatment with selective serotonin reuptake inhibitors on primate cardiovascular disease, behavior, and neuroanatomy.

Authors:  Carol A Shively; Marnie Silverstein-Metzler; Jamie Justice; Stephanie L Willard
Journal:  Neurosci Biobehav Rev       Date:  2016-08-30       Impact factor: 8.989

10.  Neurotransmitter Pathway Genes in Cognitive Decline During Aging: Evidence for GNG4 and KCNQ2 Genes.

Authors:  Luke W Bonham; Daniel S Evans; Yongmei Liu; Steven R Cummings; Kristine Yaffe; Jennifer S Yokoyama
Journal:  Am J Alzheimers Dis Other Demen       Date:  2018-01-16       Impact factor: 2.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.